Sanofi Could Turn Its Attention to BioMarin (BMRN) After Selling Regeneron Stake - RBC
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay speculated that Sanofi's (NYSE: SNY) sale the majority of its Regeneron (NASDAQ: REGN) stake could ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
